InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
T+90 hit rate
0%
T+90 mean return
-41.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by de Verneuil Vanina, Directeur Juridique. Director active across 1 company, notably Vir Biotechnology, Inc.. Cumulatively, 7 filings have been recorded. Split: 0 buy · 6 sells. Total volume traded: €165k. Activity tracked since 1 November 2024. The latest transaction was filed on 24 February 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
3,117 shares@ US$9.532650.0% of flowCommon StockSEC:0001628280-26-012393
3,117 shares@ US$9.53260.0030% mcap50.0% of flowCommon StockSEC:0001628280-26-012393:0
7,373 shares@ US$9.141838.8% of flowCommon StockSEC:0001628280-25-008499:0
35,000 shares0Common StockSEC:0001628280-25-007690:0
76 shares@ US$8.22010.4% of flowCommon StockSEC:0001628280-24-049897:0
4,397 shares@ US$10.1124.6% of flowCommon StockSEC:0001628280-24-046462:0
1,403 shares@ US$7.20395.6% of flowCommon StockSEC:0001628280-24-045387:0
7 of 7 declarations
About de Verneuil Vanina
de Verneuil Vanina is the Executive Vice President, General Counsel, and Corporate Secretary at Vir Biotechnology, Inc. She oversees the company's legal affairs and compliance, ensuring adherence to regulations. Her role is essential in protecting the company's interests and advising management on legal matters. Through her expertise, she contributes to risk management and informed decision-making.
